Business Context and Reporting Period
Tenon Medical, Inc. (TNON) filed this Form 8-K on February 25, 2026, regarding a listing deficiency notice received from The Nasdaq Stock Market LLC. The company is an emerging growth company incorporated in Delaware with principal executive offices in Los Gatos, CA.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the company's stock price performance relative to Nasdaq listing requirements.
Material Changes
The material event reported is the failure of the company's common stock to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days between January 9, 2026, and February 24, 2026. This non-compliance triggered a notification under Nasdaq Listing Rule 5550(a)(2).
Guidance, Outlook, and Risks
- Compliance Period: The company has been granted an initial 180-day compliance period ending August 24, 2026, to regain compliance.
- Requirements: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days during the compliance period.
- Future Options: If compliance is not met by August 24, 2026, the company may be eligible for an additional 180-day period, provided it meets other listing standards and notifies Nasdaq of its intention to cure the deficiency, potentially via a reverse stock split.
- Risks: There is no assurance the company will regain compliance. Failure to do so could result in delisting. The company is currently evaluating its options.
- Current Status: The notice has no immediate effect on the listing; the stock continues to trade under the symbol "TNON" on The Nasdaq Capital Market.
Investor Verification Checklist
- Verify the current trading price of TNON to assess the gap from the $1.00 threshold.
- Review the company's most recent Form 10-K and 10-Q for financial health and liquidity to evaluate the feasibility of a reverse stock split or other capital actions.
- Monitor upcoming announcements regarding the company's specific plan to regain compliance before the August 24, 2026 deadline.
- Check for any subsequent filings regarding the potential for an additional compliance period if the initial deadline is missed.